The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...

IGI reported that it has recently wrapped up the dose-escalation phase of its Phase 1 clinical trial involving patients with ...

The final ALCYONE analysis with 86.7-month follow-up shows daratumumab-VMP significantly improved overall survival in ...

Following promising phase 1 data, ISB 2001 has gained fast track designation from the FDA for the treatment of ...

Exome sequencing (ES) is commonly used to diagnose Mendelian disorders, which occur when pathogenic variant(s) in a gene are ...

UnityPoint Health proudly celebrates a $14 million investment in cancer care, designed to meet the growing need for ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

Glenmark Pharma's innovation arm, IGI, received FDA fast track designation for its myeloma therapy ISB 2001, targeting ...

A new bone marrow test can help doctors predict risk of leukemia relapse. The test might double survival rates by predicting ...

Exercise can mitigate some of the side effects of cancer treatments across a range of cancer types, according to a recent ...